24 Oct 2025 | 3 Mins Read
Dr Reddy's Q2 Profit Jumps 7% but Falls Short of Estimates.
Flipitmoney
Dr Reddy's Laboratories Limited Q2 net profit rises 7 percent YoY to Rs 1,347.1 crore, lower than estimated Rs 1,450 crore. Revenue from operations rose 10% YoY to Rs 8,828 crore, surpassing Rs 8,700 crore estimate. Stiff competition in North America's Revlimid market contributed to underperformance.